Ulobetasol: Difference between revisions
No edit summary |
No edit summary |
||
Line 55: | Line 55: | ||
}} | }} | ||
__NOTOC__ | __NOTOC__ | ||
{{SI}} | {{SI}} | ||
{{CMG}} | {{CMG}} | ||
==Overview== | ==Overview== | ||
'''Ulobetasol''' ([[International Nonproprietary Name|INN]]) or '''halobetasol''' ([[United States Adopted Name|USAN]]) is a [[corticosteroid]] used to treat [[psoriasis]]. It is a group I corticosteroid under the US classification, the most potent class of such drugs. Halobetasol propionate is usually supplied as a 0.05% topical cream. | '''Ulobetasol''' ([[International Nonproprietary Name|INN]]) or '''halobetasol''' ([[United States Adopted Name|USAN]]) is a [[corticosteroid]] used to treat [[psoriasis]]. It is a group I corticosteroid under the US classification, the most potent class of such drugs. Halobetasol propionate is usually supplied as a 0.05% topical cream. | ||
Line 65: | Line 62: | ||
{{reflist|2}} | {{reflist|2}} | ||
[[Category:Glucocorticoids]] | [[Category:Glucocorticoids]] |
Revision as of 15:08, 17 April 2015
Clinical data | |
---|---|
Synonyms | (6S,8S,9S,10S,11S,13S,14S,16S,17R)-17-(2-Chloroacetyl)-6,9-difluoro-11,17-dihydroxy-10,13,16-trimethyl-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-3-one |
AHFS/Drugs.com | Micromedex Detailed Consumer Information |
MedlinePlus | a601060 |
ATC code | |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
UNII | |
KEGG | |
ChEMBL | |
E number | {{#property:P628}} |
ECHA InfoCard | {{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value). |
Chemical and physical data | |
Formula | C22H27ClF2O4 |
Molar mass | 428.897 |
3D model (JSmol) | |
| |
| |
(what is this?) (verify) |
WikiDoc Resources for Ulobetasol |
Articles |
---|
Most recent articles on Ulobetasol |
Media |
Evidence Based Medicine |
Clinical Trials |
Ongoing Trials on Ulobetasol at Clinical Trials.gov Clinical Trials on Ulobetasol at Google
|
Guidelines / Policies / Govt |
US National Guidelines Clearinghouse on Ulobetasol
|
Books |
News |
Commentary |
Definitions |
Patient Resources / Community |
Patient resources on Ulobetasol Discussion groups on Ulobetasol Patient Handouts on Ulobetasol Directions to Hospitals Treating Ulobetasol Risk calculators and risk factors for Ulobetasol
|
Healthcare Provider Resources |
Causes & Risk Factors for Ulobetasol |
Continuing Medical Education (CME) |
International |
|
Business |
Experimental / Informatics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Ulobetasol (INN) or halobetasol (USAN) is a corticosteroid used to treat psoriasis. It is a group I corticosteroid under the US classification, the most potent class of such drugs. Halobetasol propionate is usually supplied as a 0.05% topical cream.
References
- Pages with script errors
- Template:drugs.com link with non-standard subpage
- Articles with changed CASNo identifier
- Articles with changed EBI identifier
- E number from Wikidata
- ECHA InfoCard ID from Wikidata
- Chemical articles with unknown parameter in Infobox drug
- Chemical pages without DrugBank identifier
- Drugs with no legal status
- Drugboxes which contain changes to verified fields
- Glucocorticoids
- Organofluorides
- Organochlorides
- Alcohols
- Ketones
- Drug